Purchase Order HHSN272201400757P
Award Date 7/22/14
Potential Completion Date 7/27/14
Potential Value $9.2K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
3
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. National Institute of Allergy and Infectious Diseases (NIAID), a civilian federal agency, awarded a Firm Fixed Price Blanket Purchase Agreement (BPA) Call contract worth $8,359.78 to Atlanta Biologicals, Inc. to provide Fetal Bovine Serum - Premium (Characterized). The contract has an ultimate completion date of August 18, 2017 and was awarded on July 27, 2017. The contract is not set-aside. As a Firm Fixed Price BPA Call contract, the awardee will provide the specified product at a...
- <p>The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm fixed-price purchase order contract to Biowest USA Inc., a for-profit organization, for the procurement of fetal bovine serum of USDA origin. The total potential value of the contract is $19,906.46 and the performance period runs through July 31, 2024. This contract has been set aside for small businesses.</p>
- The National Institute of Child Health and Human Development (NICHD) awarded a contract to Atlanta Biologicals, Inc. for the supply of fetal bovine serum with a ceiling value of $9,040.31. This contract was awarded on August 3, 2016, under a Blanket Purchase Agreement (BPA) call with firm fixed pricing and no set-aside designation. The work is to be performed in Bethesda, Maryland, with an ultimate completion date of August 2, 2017. Fetal bovine serum is a critical component used in cell culture...
- This is a $11,760.00 firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Life Technologies Corporation, a manufacturer of scientific instruments, reagents, and consumables. The contract is for the delivery of 120 bottles of US Qualified FBS (Fetal Bovine Serum) catalog number 26140079 at $98.00 per bottle. This contract does not have a set-aside designation. As a division of Thermo Fisher Scientific, Life Technologies has...
- This federal contract award is for the provision of fetal bovine serum to the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases. The $19,780 firm fixed-price purchase order was awarded to Omega Scientific, Inc., a for-profit small business contractor, on August 25, 2017 with a completion date of September 30, 2017. This purchase order supports the research activities of the NIH, which conducts and funds medical...
- This firm fixed-price purchase order contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the U.S. Department of Health and Human Services, to Bio-Techne Sales Corporation, a for-profit organization specializing in biological research products and materials. The $12,757.50 contract is for the delivery of fetal bovine serum, a critical research material used in various medical and scientific research programs. The award has no...
- The U.S. Department of Health and Human Services' National Institute of Allergy and Infectious Diseases (NIAID) awarded a $26,208.00 purchase order contract to Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific, for the delivery of 80 bottles of US Origin Certified FBS (Fetal Bovine Serum), Cat. # 16000044 with a completion date of August 9, 2015. This contract was awarded on a firm-fixed price basis and did not utilize any set-aside designations. Life Technologies...
- This firm fixed price purchase order, valued at $37,114, was awarded by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases to Global Life Sciences Solutions USA LLC. The contract calls for the delivery of 100 units of Hyclone-Cytiva Fetal Bovine Serum at 500ml per unit to a location in Bethesda, Maryland. This matches the key requirements laid out in the original solicitation, which mandated the specific brand of FBS...
- This firm-fixed-price federal contract award for "BOVINE SERUM" was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the Department of Health and Human Services. The $11,704.00 purchase order was awarded to Fisher Scientific Company L.L.C., a major supplier of scientific products, equipment, and services to government agencies. The contract did not utilize any set-aside designations. Fisher Scientific is a subsidiary of the Thermo Electron...
- The Department of Health and Human Services National Institutes of Health National Institute of Child Health and Human Development awarded Atlanta Biologicals, Inc. a $5,380 purchase order contract to deliver Fetal Bovine Serum, Lot #D14043, in reference to Quote #26317. The contract has a period of performance from May 12, 2015 through June 3, 2015 and utilizes a firm fixed price payment structure. Atlanta Biologicals, Inc. will perform as the prime contractor, fulfilling the order from its...
This is a $9,151.64 firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the Department of Health and Human Services (HHS), to Atlanta Biologicals Incorporated. The contract is for the purchase of fetal bovine serum (FBS). There is no set-aside designation indicated. The purchase order was awarded on July 22, 2014 with a completion date of July 27, 2014.
Generated 11/24/24, 9:02 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.2k | 7/22/14 |